{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:50:07Z","timestamp":1740135007965,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R25CA057726"],"award-info":[{"award-number":["R25CA057726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["UO1CA\/ES66572","R01CA109753","3R01CA109753-04S1","P30ES009089","Z99 ES99999"],"award-info":[{"award-number":["UO1CA\/ES66572","R01CA109753","3R01CA109753-04S1","P30ES009089","Z99 ES99999"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["BC972772"],"award-info":[{"award-number":["BC972772"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Reproductive characteristics are well-established risk factors for breast cancer, but the underlying mechanisms are not fully resolved. We hypothesized that altered DNA methylation, measured in tumor tissue, could act in concert with reproductive factors to impact breast carcinogenesis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Among a population-based sample of women newly diagnosed with first primary breast cancer, reproductive history was assessed using a life-course calendar approach in an interviewer-administered questionnaire. Methylation-specific polymerase chain reaction and Methyl Light assays were used to assess gene promotor methylation status (methylated vs. unmethylated) for 13 breast cancer-related genes in archived breast tumor tissue. We used case-case unconditional logistic regression to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for associations with age at menarche and parity (among 855 women), and age at first birth and lactation (among a subset of 736 parous women) in association with methylation status.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Age at first birth &gt;\u200927\u2009years, compared with &lt;\u200923\u2009years, was associated with lower odds of methylation of <jats:italic>CDH1<\/jats:italic> (OR\u2009=\u20090.44, 95% CI\u2009=\u20090.20\u20130.99) and <jats:italic>TWIST1<\/jats:italic> (OR\u2009=\u20090.48, 95% CI\u2009=\u20090.28\u20130.82), and higher odds of methylation of <jats:italic>BRCA1<\/jats:italic> (OR\u2009=\u20091.63, 95% CI\u2009=\u20091.14\u20132.35). Any vs. no lactation was associated with higher odds of methylation of the <jats:italic>PGR<\/jats:italic> gene promoter (OR\u2009=\u20091.59, 95% CI\u2009=\u20091.01\u20132.49). No associations were noted for parity and methylation in any of the genes assayed.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings indicate that age at first birth, lactation and, perhaps age at menarche, are associated with gene promoter methylation in breast cancer, and should be confirmed in larger studies with robust gene coverage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6120-4","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T10:03:22Z","timestamp":1568801002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-9540","authenticated-orcid":false,"given":"Lauren E.","family":"McCullough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay J.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumitra","family":"Shantakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina M.","family":"Santella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilie D.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"issue":"1","key":"6120_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.maturitas.2004.04.011","volume":"49","author":"J Russo","year":"2004","unstructured":"Russo J, Russo IH. Development of the human breast. Maturitas. 2004;49(1):2\u201315.","journal-title":"Maturitas"},{"issue":"4","key":"6120_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3816\/CBC.2008.n.038","volume":"8","author":"EH Ruder","year":"2008","unstructured":"Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer. 2008;8(4):334\u201342.","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"6120_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr921","volume":"6","author":"SE Hankinson","year":"2004","unstructured":"Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213\u20138.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"6120_CR4","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1093\/carcin\/bgs201","volume":"33","author":"HC Wu","year":"2012","unstructured":"Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, Ferris JS, et al. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the breast Cancer family registry. Carcinogenesis. 2012;33(10):1946\u201352.","journal-title":"Carcinogenesis"},{"issue":"7","key":"6120_CR5","first-page":"1998","volume":"7","author":"AK Virmani","year":"2001","unstructured":"Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001;7(7):1998\u20132004.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6120_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-011-1712-y","volume":"131","author":"YH Cho","year":"2012","unstructured":"Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, et al. Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat. 2012;131(1):197\u2013205.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6120_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/hdy.2010.2","volume":"105","author":"V Bollati","year":"2010","unstructured":"Bollati V, Baccarelli A. Environmental epigenetics. Heredity (Edinb). 2010;105(1):105\u201312.","journal-title":"Heredity (Edinb)"},{"issue":"10","key":"6120_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00439-012-1189-8","volume":"131","author":"VK Cortessis","year":"2012","unstructured":"Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, Siegmund KD, et al. Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet. 2012;131(10):1565\u201389.","journal-title":"Hum Genet"},{"issue":"2","key":"6120_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1017\/S2040174412000694","volume":"4","author":"MH Tao","year":"2013","unstructured":"Tao MH, Marian C, Shields PG, Potischman N, Nie J, Krishnan SS, et al. Exposures in early life: associations with DNA promoter methylation in breast tumors. J Dev Orig Health Dis. 2013;4(2):182\u201390.","journal-title":"J Dev Orig Health Dis"},{"issue":"3","key":"6120_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/A:1016387020854","volume":"74","author":"MD Gammon","year":"2002","unstructured":"Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The Long Island breast Cancer study project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002;74(3):235\u201354.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"6120_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/741942610","volume":"6","author":"RF Belli","year":"1998","unstructured":"Belli RF. The structure of autobiographical memory and the event history calendar: potential improvements in the quality of retrospective reports in surveys. Memory. 1998;6(4):383\u2013406.","journal-title":"Memory"},{"issue":"3","key":"6120_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-006-9343-4","volume":"102","author":"S Shantakumar","year":"2007","unstructured":"Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, et al. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat. 2007;102(3):365\u201374.","journal-title":"Breast Cancer Res Treat"},{"issue":"9b","key":"6120_CR13","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1111\/j.1582-4934.2008.00553.x","volume":"13","author":"P Rossner Jr","year":"2009","unstructured":"Rossner P Jr, Gammon MD, Zhang YJ, Terry MB, Hibshoosh H, Memeo L, et al. Mutations in p53, p53 protein overexpression and breast cancer survival. J Cell Mol Med. 2009;13(9b):3847\u201357.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"6120_CR14","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4161\/epi.6.11.17744","volume":"6","author":"X Xu","year":"2011","unstructured":"Xu X, Gammon MD, Jefferson E, Zhang Y, Cho YH, Wetmur JG, et al. The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics. 2011;6(11):1276\u201383.","journal-title":"Epigenetics"},{"issue":"2","key":"6120_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-008-0075-5","volume":"115","author":"X Xu","year":"2009","unstructured":"Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, et al. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat. 2009;115(2):397\u2013404.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6120_CR16","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1096\/fj.11-197251","volume":"26","author":"X Xu","year":"2012","unstructured":"Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, et al. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J. 2012;26(6):2657\u201366.","journal-title":"FASEB J"},{"issue":"15","key":"6120_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/S0024-3205(03)00544-7","volume":"73","author":"ZJ Liu","year":"2003","unstructured":"Liu ZJ, Maekawa M, Horii T, Morita M. The multiple promoter methylation profile of PR gene and ERalpha gene in tumor cell lines. Life Sci. 2003;73(15):1963\u201372.","journal-title":"Life Sci"},{"issue":"10","key":"6120_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1101\/gr.6.10.995","volume":"6","author":"UE Gibson","year":"1996","unstructured":"Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6(10):995\u20131001.","journal-title":"Genome Res"},{"issue":"4","key":"6120_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"8","key":"6120_CR20","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000;28(8):E32.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"6120_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","volume":"8","author":"S Ogino","year":"2006","unstructured":"Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn. 2006;8(2):209\u201317.","journal-title":"J Mol Diagn"},{"issue":"2","key":"6120_CR22","first-page":"173","volume":"3","author":"CB Begg","year":"1994","unstructured":"Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomark Prev. 1994;3(2):173\u20135.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6120_CR23","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187-95.","DOI":"10.1016\/S0140-6736(02)09454-0"},{"issue":"1","key":"6120_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36\u201347.","journal-title":"Epidemiol Rev"},{"issue":"5","key":"6120_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/ije\/31.5.1030","volume":"31","author":"S Greenland","year":"2002","unstructured":"Greenland S, Brumback B. An overview of relations among causal modelling methods. Int J Epidemiol. 2002;31(5):1030\u20137.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"6120_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","volume":"79","author":"S Greenland","year":"1989","unstructured":"Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79(3):340\u20139.","journal-title":"Am J Public Health"},{"issue":"5","key":"6120_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1349-7006.2000.tb00976.x","volume":"91","author":"Y Niwa","year":"2000","unstructured":"Niwa Y, Oyama T, Nakajima T. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn J Cancer Res. 2000;91(5):519\u201326.","journal-title":"Jpn J Cancer Res"},{"issue":"23","key":"6120_CR28","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F van Roy","year":"2008","unstructured":"van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756\u201388.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"6120_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2005.09.020","volume":"123","author":"S Yamada","year":"2005","unstructured":"Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell. 2005;123(5):889\u2013901.","journal-title":"Cell"},{"issue":"1","key":"6120_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/bcr3065","volume":"14","author":"JL Andrews","year":"2012","unstructured":"Andrews JL, Kim AC, Hens JR. The role and function of cadherins in the mammary gland. Breast Cancer Res. 2012;14(1):203.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"6120_CR31","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1096\/fj.08-128702","volume":"23","author":"G Benton","year":"2009","unstructured":"Benton G, Crooke E, George J. Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J. 2009;23(11):3884\u201395.","journal-title":"FASEB J"},{"issue":"29","key":"6120_CR32","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1038\/sj.onc.1204505","volume":"20","author":"CW Cheng","year":"2001","unstructured":"Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 2001;20(29):3814\u201323.","journal-title":"Oncogene"},{"issue":"4","key":"6120_CR33","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3892\/ol.2016.4274","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu J, Sun X, Qin S, Wang H, Du N, Li Y, et al. CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. Oncol Lett. 2016;11(4):2635\u201343.","journal-title":"Oncol Lett"},{"issue":"2","key":"6120_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, et al. Comprehensive molecular portraits of invasive lobular breast Cancer. Cell. 2015;163(2):506\u201319.","journal-title":"Cell"},{"issue":"6","key":"6120_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1245\/ASO.2005.04.010","volume":"12","author":"TA Martin","year":"2005","unstructured":"Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005;12(6):488\u201396.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"6120_CR36","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1158\/1055-9965.EPI-09-0678","volume":"18","author":"MM Gaudet","year":"2009","unstructured":"Gaudet MM, Campan M, Figueroa JD, Yang XR, Lissowska J, Peplonska B, et al. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomark Prev. 2009;18(11):3036\u201343.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"6120_CR37","doi-asserted-by":"publisher","first-page":"e91805","DOI":"10.1371\/journal.pone.0091805","volume":"9","author":"A Avraham","year":"2014","unstructured":"Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, et al. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer. PLoS One. 2014;9(3):e91805.","journal-title":"PLoS One"},{"issue":"2","key":"6120_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-013-2738-0","volume":"142","author":"SA Bardowell","year":"2013","unstructured":"Bardowell SA, Parker J, Fan C, Crandell J, Perou CM, Swift-Scanlan T. Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns. Breast Cancer Res Treat. 2013;142(2):365\u201380.","journal-title":"Breast Cancer Res Treat"},{"issue":"1\u20132","key":"6120_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1155\/2007\/291538","volume":"23","author":"LB Hesson","year":"2007","unstructured":"Hesson LB, Cooper WN, Latif F. The role of RASSF1A methylation in cancer. Dis Markers. 2007;23(1\u20132):73\u201387.","journal-title":"Dis Markers"},{"issue":"3","key":"6120_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1593\/tlo.13244","volume":"6","author":"V Kajabova","year":"2013","unstructured":"Kajabova V, Smolkova B, Zmetakova I, Sebova K, Krivulcik T, Bella V, et al. RASSF1A promoter methylation levels positively correlate with estrogen receptor expression in breast Cancer patients. Transl Oncol. 2013;6(3):297\u2013304.","journal-title":"Transl Oncol"},{"issue":"33","key":"6120_CR41","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1200\/JCO.2010.33.6446","volume":"29","author":"E Lee","year":"2011","unstructured":"Lee E, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, et al. Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol. 2011;29(33):4373\u201380.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6120-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T12:20:52Z","timestamp":1600345252000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6120"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6120-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board approval was obtained by all participating institutions (Columbia University, University of North Carolina Chapel Hill, and Emory University).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S. Shantakumar is employed at Glaxosmithkline and owns shares. A. Neugut serves as a consultant for Otsuka Pharmaceuticals, Pfizer, Eisai, Hospira, Teva, and United Biosource Corp, and is also a member of the medical advisory board of EHE Intl. No potential conflicts of interest were disclosed by the other authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}